Wordt geladen...
Trastuzumab-induced cardiotoxicity: testing a clinical risk score in a real-world cardio-oncology population
BACKGROUND: Trastuzumab has improved survival for women with her2-positive breast cancer, but its use is associated with an increased risk of cardiotoxicity. With increased survivorship, the long-term effects of cancer treatment are an important consideration for clinicians and patients. We reviewed...
Bewaard in:
| Gepubliceerd in: | Curr Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Multimed Inc.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486382/ https://ncbi.nlm.nih.gov/pubmed/28680277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.24.3349 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|